Company intelligence / Profile preview

Bioss

Woburn, Massachusetts, United Statesbiossusa.com ↗

Ownership: Private
Employees: ~14
Development stage: Commercial

Overview

Bioss is a leading developer and manufacturer of antibodies, recombinant proteins, IHC kits, ELISA kits, and related products used in life science research and in vitro diagnostics. The company offers over 18,000 primary antibodies and more than 300,000 derived products to support scientific discovery across multiple fields including immunology, cancer biology, neuroscience, cell biology, stem cells research, infectious disease studies and more. Its products are widely used by academic labs as well as biotech/pharma companies globally.

Modalities: AntibodyMonoclonal antibodyPolyclonal antibodyRecombinant protein
Industry: Protein Biomarker Diagnostics

Partnerships

No major pharma/biotech partnerships disclosed; distributes through global partners/resellers.

Beyond the preview

Go deeper on Bioss.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioss.

Explore the full profile